Inhibition of nuclear factor kappaB by sulfasalazine: a new target for inflammatory bowel disease therapy?
Article Details
- CitationCopy to clipboard
Egan LJ, Sandborn WJ
Inhibition of nuclear factor kappaB by sulfasalazine: a new target for inflammatory bowel disease therapy?
Gastroenterology. 1998 Nov;115(5):1295-6.
- PubMed ID
- 9797390 [ View in PubMed]
- Abstract
Not Available
DrugBank Data that Cites this Article
- Drug Targets
Drug Target Kind Organism Pharmacological Action Actions Olsalazine Interferon gamma Protein Humans YesNot Available Details